Your browser doesn't support javascript.
loading
The use of aripiprazole in early onset schizophrenia: safety and efficacy.
Normala, I; Hamidin, A.
Afiliación
  • Normala I; Department of Psychiatry, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. nmala@medic.upm.edu.my
Med J Malaysia ; 64(3): 240-1, 2009 Sep.
Article en En | MEDLINE | ID: mdl-20527278
The use of atypical antipsychotic agents in early onset schizophrenia is rising despite its limited data on efficacy, safety and tolerability. Early onset schizophrenia warrants effective pharmacological treatment that is safe and well tolerated by children and adolescent population. Existing atypical agents are not completely free of side effects. Aripiprazole has unique properties that differ from other atypical antipsychotics and fill up the missing gaps, as it is associated with minimal metabolic complications and extrapyramidal side effects that are more commonly seen in other atypical agents. It offers a better option for this population and may possibly be considered as first line treatment in future. This case report demonstrates the efficacy and safety of Aripiprazole in children and adolescent population.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperazinas / Esquizofrenia / Antipsicóticos / Quinolonas Límite: Adolescent / Female / Humans Idioma: En Revista: Med J Malaysia Año: 2009 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Malasia
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperazinas / Esquizofrenia / Antipsicóticos / Quinolonas Límite: Adolescent / Female / Humans Idioma: En Revista: Med J Malaysia Año: 2009 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Malasia